Trial intelligence / Profile preview

ICG Imaging for Peritoneal Metastases in Gastric Cancer

NCT05687617Phase 2Terminated

Sponsor
Université Laval
Start
Dec 2022
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of indocyanine green in gastric adenocarcinoma, sponsored by Université Laval. Started Dec 2022; status: terminated.

02

Drugs

indocyanine green
03

Conditions

gastric adenocarcinoma

Beyond the preview

Go deeper on NCT05687617.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05687617.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call